Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
NAR Cancer
|
October 7, 2024
RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines
Izabela Todorovski, Mary-Jane Tsang, Breon Feran, et al.
NAR Genomics and Bioinformatics
|
August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
Olivia Craig, Samuel Lee, Courtney Pilcher, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Cancers
|
November 27, 2021
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
Kathleen I Pishas, Karla J Cowley, Ahwan Pandey, et al.
Molecular Cell
|
August 26, 2025
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation
Jennifer R Devlin, Ben Martin, Nenad Bartonicek, et al.
Plos Genetics
|
October 17, 2018
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer
Tamara Zoranovic, Jan Manent, Lee Willoughby, et al.
The Journal of Pathology
|
May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
Kathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 17, 2012
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens
Victoria A Meliopoulos, Lauren E Andersen, Katherine F Birrer, et al.
Cancer Discovery
|
March 28, 2018
Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant Growth
Helen B Pearson, Jason Li, Valerie S Meniel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Ankita Gupte, Emma K Baker, Soo-San Wan, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
NAR Cancer
|
October 7, 2024
RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines
Izabela Todorovski, Mary-Jane Tsang, Breon Feran, et al.
NAR Genomics and Bioinformatics
|
August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
Olivia Craig, Samuel Lee, Courtney Pilcher, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Cancers
|
November 27, 2021
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
Kathleen I Pishas, Karla J Cowley, Ahwan Pandey, et al.
Molecular Cell
|
August 26, 2025
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation
Jennifer R Devlin, Ben Martin, Nenad Bartonicek, et al.
Plos Genetics
|
October 17, 2018
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer
Tamara Zoranovic, Jan Manent, Lee Willoughby, et al.
The Journal of Pathology
|
May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
Kathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 17, 2012
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens
Victoria A Meliopoulos, Lauren E Andersen, Katherine F Birrer, et al.
Cancer Discovery
|
March 28, 2018
Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant Growth
Helen B Pearson, Jason Li, Valerie S Meniel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2015
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Ankita Gupte, Emma K Baker, Soo-San Wan, et al.
Page
of 12